Latest news

Thumbnail image for EU green light for Takeda’s Alunbrig

EU green light for Takeda’s Alunbrig

Takeda’s Alunbrig has been approved in Europe as a treatment for a specific group of lung cancer patients, but access to the drug in the UK remains uncertain.

27th November 2018

Thumbnail image for US approves first ever TRK inhibitor

US approves first ever TRK inhibitor

Bayer and Loxo Oncology’s Vitrakvi has become the first ever TRK inhibitor to be approved in the US, having been cleared to treat advanced solid tumours harbouring an NTRK gene fusion.

27th November 2018

Thumbnail image for First children set to receive Novartis’ Kymriah

First children set to receive Novartis’ Kymriah

The first children to receive Novartis’ Kymriah – a ‘game-changing’ CAR-T therapy for cancer - will start treatment at Great Ormond Street Hospital in London this week, NHS England has announced.

27th November 2018

Thumbnail image for Join the medical & scientific community at the MSEA awards 2018

Join the medical & scientific community at the MSEA awards 2018

The first edition of the PharmaTimes Medical & Scientific Excellence Awards will take place on Thursday 6th December – the competition will take place during the day, with the dinner and awards ceremony following in the evening at The Sofitel Hotel, Gatwick.

27th November 2018

Previous  --   6 7 8 9 10 11 12 13 14 15   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download